The Partners

The ULTRAsponder Consortium involves multi-disciplinary expertise split among nine partners from five European countries (France, Germany, Netherlands, Norway, and Switzerland).

Key actors in research, development and exploitation of microtechnology and health technologies are involved in the consortium, such as a large medical company, several SMEs, Universities and leading research organisations. A large hospital has also been included in the consortium to provide contribution in the field of security and ethics relative to the implantation of sensors in human body as well as a potential end user.